Stacie Lindsey to Receive Luminary Award for Advances in GI Cancers

Stacie C. Lindsey, Chief Executive Officer & Founder of the Cholangiocarcinoma Foundation is one of five leading individuals who will receive a Luminary Award in GI Cancers from OncLive and The Ruesch Center at their virtual 11th Annual Ruesch Symposium. The award winners are being honored for their lifetime achievements focused on finding cures for GI cancers and improving the lives of those affected by this group of most common and most fatal cancers.

“There are so many who work so hard to find cures for GI cancers; we could never thank them all. But in recognizing those who have dedicated their entire lives to GI cancer patients, we stop to give our thanks for all their effort,” said John L. Marshall, MD, chief of the Division of Hematology/Oncology at Medstar Georgetown University Hospital, professor of medicine and oncology, and director of the Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer at Georgetown-Lombardi Comprehensive Cancer Center.

Jason Scott, CCF Board Director, added, “Stacie created the Cholangiocarcinoma Foundation to honor her brother and to help other families devastated by this terrible disease. Her dedication, leadership and good heart have created a community of patients, caregivers, clinicians and researchers committed to making a difference and finding a cure. She is truly worthy of the Luminary Award.”

Stacie and her family established the foundation in 2006 to help find a cure for cholangiocarcinoma (bile duct cancer) and improve the quality of life for those affected by the disease through advocacy, education, collaboration and research. Since the foundation’s inception, she has engaged with different stakeholders in medical and academic communities; policymakers and regulators; and patients and advocates to advance research to benefit patients living with cholangiocarcinoma.

“In memory of her brother, Stacie transformed grief and loss into a living legacy in building the Cholangiocarcinoma Foundation and its far-reaching community of scientists, clinicians, patients, and families. Through her tireless leadership and vision, the CCF has become a catalyst across the translational continuum from laboratory science to clinical research to epidemiology, leading to the current renaissance in research and new therapies for cholangiocarcinoma, said Katie Kelley, MD.

Stacie is a founding member and has served on the board of directors since its inception. Stacie resides in Salt Lake City, Utah, where she is the mother of five children. She holds a Bachelor of Arts degree in Psychology from Brigham Young University, and is an active member in her church and community.

“The Luminaries Awards is our opportunity to honor those who have set a standard for us all. Each awardee’s dedication, creativity, compassion, and laser like focus on improving outcomes for GI cancer patients has translated into new standards. We give these awards to recognize their efforts and to inspire others as we continue in the fight,” said John L. Marshall, M.D., director, The Ruesch Center for the Cure of GI Cancers.

The other four Luminary Awards in GI Cancers awardees are: Richard M. Goldberg, MD, Director Emeritus of West Virginia University Cancer Institute; Gayle S. Jameson, RN, MSN, ACNP-BC, AOCN; Tyvin Rich, MD, FACR, radiation oncologist; and Diane M. Simeone, MD, Laura and Isaac Perlmutter Professor of Surgery.

The Luminary Awards in GI Cancers will be held virtually on Nov. 20-21, 2020.